These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 24098819)
1. A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. Voorend CG; Post EB PLoS Negl Trop Dis; 2013; 7(10):e2440. PubMed ID: 24098819 [TBL] [Abstract][Full Text] [Related]
2. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695 [TBL] [Abstract][Full Text] [Related]
3. Neutrophilic leukocytosis and erythema nodosum leprosum in leprosy: insights from a retrospective observational study. Feitosa da Silva Barboza M; de Andrea Hacker M; Maria Sales A; Fontoura Rodrigues D; Pedrosa Marques D; José Ciryllo Silva Noya D; Leal Silveira Andrezo Rosa T; de Fátima Alvim Braga I; Ferreira H; Porto Amadeu T; Gurgel de Oliveira M; de Miranda Machado A; Illarramendi X; Schmitz V Front Immunol; 2024; 15():1368460. PubMed ID: 39072336 [TBL] [Abstract][Full Text] [Related]
4. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Becx-Bleumink M; Berhe D Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359 [TBL] [Abstract][Full Text] [Related]
5. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum. Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631 [TBL] [Abstract][Full Text] [Related]
6. ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: incidence and risk factors. Saunderson P; Gebre S; Byass P Lepr Rev; 2000 Sep; 71(3):318-24. PubMed ID: 11105490 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for erythema nodosum leprosum. Manandhar R; LeMaster JW; Roche PW Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406 [TBL] [Abstract][Full Text] [Related]
8. Epidemiological profile and severity of erythema nodosum leprosum in Brazil: a cross-sectional study. Baima de Melo C; Silva de Sá BD; Aníbal Carvalho Costa F; Nunes Sarno E Int J Dermatol; 2020 Jul; 59(7):856-861. PubMed ID: 32358972 [TBL] [Abstract][Full Text] [Related]
9. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions. Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN Front Immunol; 2018; 9():189. PubMed ID: 29479352 [TBL] [Abstract][Full Text] [Related]
10. Household costs of leprosy reactions (ENL) in rural India. Chandler DJ; Hansen KS; Mahato B; Darlong J; John A; Lockwood DN PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003431. PubMed ID: 25590638 [TBL] [Abstract][Full Text] [Related]
11. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT. Balagon M; Saunderson PR; Gelber RH Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929 [TBL] [Abstract][Full Text] [Related]
12. A retrospective study of the severe and uncommon variants of erythema nodosum leprosum at a tertiary health center in central India. Wankhade VH; Debnath P; Singh RP; Sawatkar G; Bhat DM Int J Mycobacteriol; 2019; 8(1):29-34. PubMed ID: 30860176 [TBL] [Abstract][Full Text] [Related]
13. Epidemiological characteristics of leprosy reactions: 15 years experience from north India. Kumar B; Dogra S; Kaur I Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592 [TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia. Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793 [TBL] [Abstract][Full Text] [Related]
15. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India. Upputuri B; Pallapati MS; Tarwater P; Srikantam A PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210 [TBL] [Abstract][Full Text] [Related]
16. Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction. Rosa TLSA; Leal-Calvo T; Tavares IF; Mendes MA; Dias AA; Piauy MHDS; Barboza MFDS; Kapuscinski M; Costa FDMR; Marques MAM; Belone AFF; Sales AM; Hacker MA; Moreira MBP; Belisle JT; Moraes MO; Pessolani MCV; Schmitz V Front Immunol; 2024; 15():1366125. PubMed ID: 38715615 [TBL] [Abstract][Full Text] [Related]
17. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions. Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714 [TBL] [Abstract][Full Text] [Related]